{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:38:52Z","timestamp":1792543132548,"version":"4.5.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:00:00Z","timestamp":1792454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:00:00Z","timestamp":1792454400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2019LZL018"],"award-info":[{"award-number":["ZR2019LZL018"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U1932158, 81871085 and 82271519"],"award-info":[{"award-number":["U1932158, 81871085 and 82271519"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017128","name":"Science Fund for Distinguished Young Scholars of Anhui Province","doi-asserted-by":"publisher","award":["2208085J10"],"award-info":[{"award-number":["2208085J10"]}],"id":[{"id":"10.13039\/100017128","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Collaborative Innovation Program of Hefei Science Center","award":["2019HSC-CIP003"],"award-info":[{"award-number":["2019HSC-CIP003"]}]},{"DOI":"10.13039\/501100010246","name":"Postdoctoral Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["2019M652403"],"award-info":[{"award-number":["2019M652403"]}],"id":[{"id":"10.13039\/501100010246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018546","name":"Postdoctoral Innovation Project of Shandong Province","doi-asserted-by":"publisher","award":["202002048"],"award-info":[{"award-number":["202002048"]}],"id":[{"id":"10.13039\/501100018546","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12779-7","type":"journal-article","created":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T11:31:04Z","timestamp":1792495864000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The role of the mitochondrial phosphate carrier in modulating mitochondrial homeostasis and enhancing radiosensitivity in tumor cells"],"prefix":"10.1007","volume":"53","author":[{"given":"Lichen","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongcang","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuanghu","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junchao","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,20]]},"reference":[{"key":"12779_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijsu.2022.106969","volume":"107","author":"CY Yu","year":"2022","unstructured":"Yu CY, Huang TW, Tam KW (2022) Management of phyllodes tumor: a systematic review and meta-analysis of real-world evidence. Int J Surg 107:106969. https:\/\/doi.org\/10.1016\/j.ijsu.2022.106969","journal-title":"Int J Surg"},{"issue":"5","key":"12779_CR2","doi-asserted-by":"publisher","first-page":"319","DOI":"10.3322\/canjclin.32.5.319","volume":"32","author":"JJ Keating","year":"1982","unstructured":"Keating JJ (1982) Neurofibrosarcoma and irradiation. CA Cancer J Clin 32(5):319. https:\/\/doi.org\/10.3322\/canjclin.32.5.319","journal-title":"CA Cancer J Clin"},{"issue":"7381","key":"12779_CR3","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/nature10760","volume":"481","author":"CJ Lord","year":"2012","unstructured":"Lord CJ, Ashworth A (2012) The DNA damage response and cancer therapy. Nature 481(7381):287\u2013294. https:\/\/doi.org\/10.1038\/nature10760","journal-title":"Nature"},{"issue":"1","key":"12779_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-020-0150-x","volume":"5","author":"RX Huang","year":"2020","unstructured":"Huang RX, Zhou PK (2020) DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer. Signal Transduct Target Ther 5(1):60. https:\/\/doi.org\/10.1038\/s41392-020-0150-x","journal-title":"Signal Transduct Target Ther"},{"key":"12779_CR5","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1146\/annurev-med-081313-121208","volume":"66","author":"M Goldstein","year":"2015","unstructured":"Goldstein M, Kastan MB (2015) The DNA damage response: implications for tumor responses to radiation and chemotherapy. Annu Rev Med 66:129\u2013143. https:\/\/doi.org\/10.1146\/annurev-med-081313-121208","journal-title":"Annu Rev Med"},{"issue":"3","key":"12779_CR6","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1093\/neuonc\/noae215","volume":"27","author":"M Gallitto","year":"2025","unstructured":"Gallitto M, Zhang X, De Los Santos G, Wei HJ, Fern\u00e1ndez EC, Duan S, Sedor G, Yoh N, Kokossis D, Angel JC et al (2025) Targeted delivery of napabucasin with radiotherapy improves outcomes in diffuse midline glioma. Neuro Oncol 27(3):795\u2013810. https:\/\/doi.org\/10.1093\/neuonc\/noae215","journal-title":"Neuro Oncol"},{"key":"12779_CR7","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.canlet.2020.10.050","volume":"499","author":"T Jiang","year":"2021","unstructured":"Jiang T, Nam DH, Ram Z, Poon WS, Wang J, Boldbaatar D, Mao Y, Ma W, Mao Q, You Y et al (2021) Clinical practice guidelines for the management of adult diffuse gliomas. Cancer Lett 499:60\u201372. https:\/\/doi.org\/10.1016\/j.canlet.2020.10.050","journal-title":"Cancer Lett"},{"issue":"12 Suppl 2","key":"12779_CR8","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1093\/neuonc\/noad258","volume":"26","author":"CL Tseng","year":"2024","unstructured":"Tseng CL, Zeng KL, Mellon EA, Soltys SG, Ruschin M, Lau AZ, Lutsik NS, Chan RW, Detsky J, Stewart J et al (2024) Evolving concepts in margin strategies and adaptive radiotherapy for glioblastoma: a new future is on the horizon. Neuro Oncol 26(12 Suppl 2):S3-s16. https:\/\/doi.org\/10.1093\/neuonc\/noad258","journal-title":"Neuro Oncol"},{"issue":"8","key":"12779_CR9","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106FromNLM","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, Hawkins C, Ng HK, Pfister SM, Reifenberger G et al (2021) The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol 23(8):1231\u20131251. https:\/\/doi.org\/10.1093\/neuonc\/noab106FromNLM","journal-title":"Neuro Oncol"},{"issue":"8","key":"12779_CR10","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1093\/neuonc\/noaf086","volume":"27","author":"X Yu","year":"2025","unstructured":"Yu X, Song X, Tiek D, Wu R, Walker M, Horbinski C, Hu B, Cheng SY (2025) Targeting PDGFRA-SHP2 signaling enhances radiotherapy in IDH1-mutant glioma. Neuro Oncol 27(8):2023\u20132034. https:\/\/doi.org\/10.1093\/neuonc\/noaf086","journal-title":"Neuro Oncol"},{"key":"12779_CR11","doi-asserted-by":"publisher","DOI":"10.1172\/jci179395","author":"A Mangoli","year":"2025","unstructured":"Mangoli A, Valentine V, Maingi SM, Wu SR, Liu HQ, Aksu M, Jain V, Foreman BE, Regal JA, Weidenhammer LB et al (2025) Disruption of ataxia telangiectasia-mutated kinase enhances radiation therapy efficacy in spatially directed diffuse midline glioma models. J Clin Invest. https:\/\/doi.org\/10.1172\/jci179395. (From NLM)","journal-title":"J Clin Invest"},{"issue":"3","key":"12779_CR12","doi-asserted-by":"publisher","first-page":"420","DOI":"10.4103\/mgr.MEDGASRES-D-24-00096","volume":"15","author":"T Cai","year":"2025","unstructured":"Cai T (2025) Hyperbaric oxygen therapy as an adjunt treatment for glioma and brain metastasis: a literature review. Med Gas Res 15(3):420\u2013426. https:\/\/doi.org\/10.4103\/mgr.MEDGASRES-D-24-00096","journal-title":"Med Gas Res"},{"issue":"3","key":"12779_CR13","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.tem.2023.11.005","volume":"35","author":"C Mancini","year":"2024","unstructured":"Mancini C, Lori G, Pranzini E, Taddei ML (2024) Metabolic challengers selecting tumor-persistent cells. Trends Endocrinol Metab 35(3):263\u2013276. https:\/\/doi.org\/10.1016\/j.tem.2023.11.005","journal-title":"Trends Endocrinol Metab"},{"key":"12779_CR14","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.canlet.2020.01.008","volume":"474","author":"E Abad","year":"2020","unstructured":"Abad E, Graifer D, Lyakhovich A (2020) DNA damage response and resistance of cancer stem cells. Cancer Lett 474:106\u2013117. https:\/\/doi.org\/10.1016\/j.canlet.2020.01.008","journal-title":"Cancer Lett"},{"key":"12779_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/antiox14040406","author":"I Rabeya","year":"2025","unstructured":"Rabeya I, Meesungnoen J, Jay-Gerin JP (2025) Oxygen depletion and the role of cellular antioxidants in FLASH radiotherapy: mechanistic insights from Monte Carlo radiation-chemical modeling. Antioxidants (Basel). https:\/\/doi.org\/10.3390\/antiox14040406. (From NLM)","journal-title":"Antioxidants (Basel)"},{"issue":"1","key":"12779_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-022-02430-1","volume":"41","author":"X Bao","year":"2022","unstructured":"Bao X, Xie L (2022) Targeting purinergic pathway to enhance radiotherapy-induced immunogenic cancer cell death. J Exp Clin Cancer Res 41(1):222. https:\/\/doi.org\/10.1186\/s13046-022-02430-1","journal-title":"J Exp Clin Cancer Res"},{"key":"12779_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2025.101385","volume":"105","author":"J Xia","year":"2025","unstructured":"Xia J, Jin J, Dai S, Fan H, Chen K, Li J, Luo F, Peng X (2025) Mitophagy: a key regulator of radiotherapy resistance in the tumor immune microenvironment. Mol Aspects Med 105:101385. https:\/\/doi.org\/10.1016\/j.mam.2025.101385","journal-title":"Mol Aspects Med"},{"issue":"10","key":"12779_CR18","doi-asserted-by":"publisher","DOI":"10.1093\/nsr\/nwae350","volume":"11","author":"Y Ma","year":"2024","unstructured":"Ma Y, Zhang W, Zhao Z, Lv J, Chen J, Yan X, Lin X, Zhang J, Wang B, Gao S et al (2024) Current views on mechanisms of the FLASH effect in cancer radiotherapy. Natl Sci Rev 11(10):nwae350. https:\/\/doi.org\/10.1093\/nsr\/nwae350. (From NLM)","journal-title":"Natl Sci Rev"},{"issue":"2","key":"12779_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajps.2024.100903","volume":"19","author":"X Sun","year":"2024","unstructured":"Sun X, Wu L, Du L, Xu W, Han M (2024) Targeting the organelle for radiosensitization in cancer radiotherapy. Asian J Pharm Sci 19(2):100903. https:\/\/doi.org\/10.1016\/j.ajps.2024.100903","journal-title":"Asian J Pharm Sci"},{"issue":"6","key":"12779_CR20","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/nrd3137","volume":"9","author":"S Fulda","year":"2010","unstructured":"Fulda S, Galluzzi L, Kroemer G (2010) Targeting mitochondria for cancer therapy. Nat Rev Drug Discov 9(6):447\u2013464. https:\/\/doi.org\/10.1038\/nrd3137","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"12779_CR21","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/cr.2017.155FromNLM","volume":"28","author":"PE Porporato","year":"2018","unstructured":"Porporato PE, Filigheddu N, Pedro JMB, Kroemer G, Galluzzi L (2018) Mitochondrial metabolism and cancer. Cell Res 28(3):265\u2013280. https:\/\/doi.org\/10.1038\/cr.2017.155FromNLM","journal-title":"Cell Res"},{"issue":"3","key":"12779_CR22","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.cmet.2020.06.019","volume":"32","author":"K Vasan","year":"2020","unstructured":"Vasan K, Werner M, Chandel NS (2020) Mitochondrial metabolism as a target for cancer therapy. Cell Metab 32(3):341\u2013352. https:\/\/doi.org\/10.1016\/j.cmet.2020.06.019","journal-title":"Cell Metab"},{"issue":"3","key":"12779_CR23","doi-asserted-by":"publisher","first-page":"130","DOI":"10.4103\/mgr.MEDGASRES-D-23-00028","volume":"14","author":"Q Deng","year":"2024","unstructured":"Deng Q, Yang X, Li Z (2024) Hyperbaric oxygen: a multifaceted approach in cancer therapy. Med Gas Res 14(3):130\u2013132. https:\/\/doi.org\/10.4103\/mgr.MEDGASRES-D-23-00028","journal-title":"Med Gas Res"},{"issue":"1","key":"12779_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/bj20081386","volume":"417","author":"MP Murphy","year":"2009","unstructured":"Murphy MP (2009) How mitochondria produce reactive oxygen species. Biochem J 417(1):1\u201313. https:\/\/doi.org\/10.1042\/bj20081386","journal-title":"Biochem J"},{"issue":"5516","key":"12779_CR25","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1126\/science.1058079","volume":"292","author":"T Pfeiffer","year":"2001","unstructured":"Pfeiffer T, Schuster S, Bonhoeffer S (2001) Cooperation and competition in the evolution of ATP-producing pathways. Science 292(5516):504\u2013507. https:\/\/doi.org\/10.1126\/science.1058079","journal-title":"Science"},{"key":"12779_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2025.103637FromNLM","volume":"83","author":"C Uslu","year":"2025","unstructured":"Uslu C, Kapan E, Lyakhovich A (2025) OXPHOS inhibition overcomes chemoresistance in triple negative breast cancer. Redox Biol 83:103637. https:\/\/doi.org\/10.1016\/j.redox.2025.103637FromNLM","journal-title":"Redox Biol"},{"issue":"7","key":"12779_CR27","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1158\/1078-0432.Ccr-24-3296","volume":"31","author":"APM Beerkens","year":"2025","unstructured":"Beerkens APM, Heskamp S, Reinema FV, Adema GJ, Span PN, Bussink J (2025) Mitochondria targeting of oxidative phosphorylation inhibitors to alleviate hypoxia and enhance anticancer treatment efficacy. Clin Cancer Res 31(7):1186\u20131193. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-24-3296","journal-title":"Clin Cancer Res"},{"issue":"4","key":"12779_CR28","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1093\/neuonc\/noae255","volume":"27","author":"H Shen","year":"2025","unstructured":"Shen H, Mudassar F, Ma S, Wang X, Nguyen S, Bal N, Huynh QS, Wang D, Chang C, Ing P et al (2025) Inhibition of mitochondrial bioenergetics and hypoxia to radiosensitize diffuse intrinsic pontine glioma. Neuro Oncol 27(4):1061\u20131075. https:\/\/doi.org\/10.1093\/neuonc\/noae255","journal-title":"Neuro Oncol"},{"key":"12779_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-7-13","volume":"7","author":"A Lena","year":"2009","unstructured":"Lena A, Rechichi M, Salvetti A, Bartoli B, Vecchio D, Scarcelli V, Amoroso R, Benvenuti L, Gagliardi R, Gremigni V et al (2009) Drugs targeting the mitochondrial pore act as cytotoxic and cytostatic agents in temozolomide-resistant glioma cells. J Transl Med 7:13. https:\/\/doi.org\/10.1186\/1479-5876-7-13","journal-title":"J Transl Med"},{"issue":"26","key":"12779_CR30","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202401394FromNLM","volume":"11","author":"Z Zhou","year":"2024","unstructured":"Zhou Z, Jiang X, Yi L, Li C, Wang H, Xiong W, Li Z, Shen J (2024) Mitochondria energy metabolism depression as novel adjuvant to sensitize radiotherapy and inhibit radiation induced-pulmonary fibrosis. Adv Sci (Weinh) 11(26):e2401394. https:\/\/doi.org\/10.1002\/advs.202401394FromNLM","journal-title":"Adv Sci (Weinh)"},{"key":"12779_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202405494","author":"W Zhen","year":"2024","unstructured":"Zhen W, Fan Y, Germanas T, Tillman L, Li J, Blenko AL, Weichselbaum RR, Lin W (2024) Digitonin-loaded nanoscale metal-organic framework for mitochondria-targeted radiotherapy-radiodynamic therapy and disulfidptosis. Adv Mater. https:\/\/doi.org\/10.1002\/adma.202405494. (From NLM)","journal-title":"Adv Mater"},{"issue":"43","key":"12779_CR32","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202007778","volume":"33","author":"X Guo","year":"2021","unstructured":"Guo X, Yang N, Ji W, Zhang H, Dong X, Zhou Z, Li L, Shen HM, Yao SQ, Huang W (2021) Mito-bomb: targeting mitochondria for cancer therapy. Adv Mater 33(43):e2007778. https:\/\/doi.org\/10.1002\/adma.202007778","journal-title":"Adv Mater"},{"issue":"1","key":"12779_CR33","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nchembio.1712","volume":"11","author":"SE Weinberg","year":"2015","unstructured":"Weinberg SE, Chandel NS (2015) Targeting mitochondria metabolism for cancer therapy. Nat Chem Biol 11(1):9\u201315. https:\/\/doi.org\/10.1038\/nchembio.1712","journal-title":"Nat Chem Biol"},{"issue":"2","key":"12779_CR34","doi-asserted-by":"publisher","first-page":"309","DOI":"10.4103\/mgr.MEDGASRES-D-24-00089","volume":"15","author":"AA Bazzal","year":"2025","unstructured":"Bazzal AA, Hoteit BH, Chokor M, Safawi A, Zibara Z, Rizk F, Kawssan A, Danaf N, Msheik L, Hamdar H (2025) Potential therapeutic applications of medical gases in cancer treatment. Med Gas Res 15(2):309\u2013317. https:\/\/doi.org\/10.4103\/mgr.MEDGASRES-D-24-00089","journal-title":"Med Gas Res"},{"issue":"3","key":"12779_CR35","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1038\/s12276-023-00950-0","volume":"55","author":"N Thi Nguyen","year":"2023","unstructured":"Thi Nguyen N, Thi Nguyen T, Nguyen HT, Lee JM, Kim MJ, Qi XF, Cha SK, Lee IK, Park KS (2023) Inhibition of mitochondrial phosphate carrier prevents high phosphate-induced superoxide generation and vascular calcification. Exp Mol Med 55(3):532\u2013540. https:\/\/doi.org\/10.1038\/s12276-023-00950-0","journal-title":"Exp Mol Med"},{"issue":"14","key":"12779_CR36","doi-asserted-by":"publisher","first-page":"9115","DOI":"10.1016\/S0021-9258(17)47273-5","volume":"259","author":"HV Kolbe","year":"1984","unstructured":"Kolbe HV, Costello D, Wong A, Lu RC, Wohlrab H (1984) Mitochondrial phosphate transport. Large scale isolation and characterization of the phosphate transport protein from beef heart mitochondria. J Biol Chem 259(14):9115\u20139120 (From NLM)","journal-title":"J Biol Chem"},{"key":"12779_CR37","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.mito.2022.01.006","volume":"63","author":"ID Boyenle","year":"2022","unstructured":"Boyenle ID, Oyedele AK, Ogunlana AT, Adeyemo AF, Oyelere FS, Akinola OB, Adelusi TI, Ehigie LO, Ehigie AF (2022) Targeting the mitochondrial permeability transition pore for drug discovery: challenges and opportunities. Mitochondrion 63:57\u201371. https:\/\/doi.org\/10.1016\/j.mito.2022.01.006","journal-title":"Mitochondrion"},{"issue":"4","key":"12779_CR38","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1152\/physrev.00001.2015","volume":"95","author":"P Bernardi","year":"2015","unstructured":"Bernardi P, Rasola A, Forte M, Lippe G (2015) The mitochondrial permeability transition pore: channel formation by F-ATP synthase, integration in signal transduction, and role in pathophysiology. Physiol Rev 95(4):1111\u20131155. https:\/\/doi.org\/10.1152\/physrev.00001.2015","journal-title":"Physiol Rev"},{"issue":"2","key":"12779_CR39","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.cmet.2014.12.001","volume":"21","author":"JQ Kwong","year":"2015","unstructured":"Kwong JQ, Molkentin JD (2015) Physiological and pathological roles of the mitochondrial permeability transition pore in the heart. Cell Metab 21(2):206\u2013214. https:\/\/doi.org\/10.1016\/j.cmet.2014.12.001","journal-title":"Cell Metab"},{"issue":"8","key":"12779_CR40","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1038\/cdd.2014.36","volume":"21","author":"JQ Kwong","year":"2014","unstructured":"Kwong JQ, Davis J, Baines CP, Sargent MA, Karch J, Wang X, Huang T, Molkentin JD (2014) Genetic deletion of the mitochondrial phosphate carrier desensitizes the mitochondrial permeability transition pore and causes cardiomyopathy. Cell Death Differ 21(8):1209\u20131217. https:\/\/doi.org\/10.1038\/cdd.2014.36","journal-title":"Cell Death Differ"},{"issue":"1","key":"12779_CR41","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.mito.2011.04.006","volume":"12","author":"P Varanyuwatana","year":"2012","unstructured":"Varanyuwatana P, Halestrap AP (2012) The roles of phosphate and the phosphate carrier in the mitochondrial permeability transition pore. Mitochondrion 12(1):120\u2013125. https:\/\/doi.org\/10.1016\/j.mito.2011.04.006. (From NLM)","journal-title":"Mitochondrion"},{"issue":"12","key":"12779_CR42","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1038\/onc.2014.96","volume":"34","author":"M Bonora","year":"2015","unstructured":"Bonora M, Wieckowski MR, Chinopoulos C, Kepp O, Kroemer G, Galluzzi L, Pinton P (2015) Molecular mechanisms of cell death: central implication of ATP synthase in mitochondrial permeability transition. Oncogene 34(12):1475\u20131486. https:\/\/doi.org\/10.1038\/onc.2014.96. (From NLM)","journal-title":"Oncogene"},{"issue":"6","key":"12779_CR43","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.yjmcc.2009.02.021","volume":"46","author":"AP Halestrap","year":"2009","unstructured":"Halestrap AP (2009) What is the mitochondrial permeability transition pore? J Mol Cell Cardiol 46(6):821\u2013831. https:\/\/doi.org\/10.1016\/j.yjmcc.2009.02.021. (From NLM)","journal-title":"J Mol Cell Cardiol"},{"issue":"7033","key":"12779_CR44","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1038\/nature03434","volume":"434","author":"CP Baines","year":"2005","unstructured":"Baines CP, Kaiser RA, Purcell NH, Blair NS, Osinska H, Hambleton MA, Brunskill EW, Sayen MR, Gottlieb RA, Dorn GW et al (2005) Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature 434(7033):658\u2013662. https:\/\/doi.org\/10.1038\/nature03434. (From NLM)","journal-title":"Nature"},{"issue":"18","key":"12779_CR45","doi-asserted-by":"publisher","first-page":"8663","DOI":"10.1016\/S0021-9258(18)43551-X","volume":"255","author":"MC Beatrice","year":"1980","unstructured":"Beatrice MC, Palmer JW, Pfeiffer DR (1980) The relationship between mitochondrial membrane permeability, membrane potential, and the retention of Ca2+ by mitochondria. J Biol Chem 255(18):8663\u20138671","journal-title":"J Biol Chem"},{"issue":"8","key":"12779_CR46","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1007\/s00424-018-2123-2","volume":"470","author":"C Mammucari","year":"2018","unstructured":"Mammucari C, Raffaello A, Vecellio Reane D, Gherardi G, De Mario A, Rizzuto R (2018) Mitochondrial calcium uptake in organ physiology: from molecular mechanism to animal models. Pflugers Arch 470(8):1165\u20131179. https:\/\/doi.org\/10.1007\/s00424-018-2123-2. (From NLM)","journal-title":"Pflugers Arch"},{"issue":"12","key":"12779_CR47","doi-asserted-by":"publisher","first-page":"8301","DOI":"10.21037\/tcr-2025-1946","volume":"14","author":"S Deng","year":"2025","unstructured":"Deng S, Fu J (2025) SLC25A3 promotes hepatocellular carcinoma progression by inducing mitochondrial dysfunction and chromatin remodeling. Transl Cancer Res 14(12):8301\u20138312. https:\/\/doi.org\/10.21037\/tcr-2025-1946","journal-title":"Transl Cancer Res"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12779-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12779-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12779-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:05:18Z","timestamp":1792541118000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12779-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,20]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12779"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12779-7","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,20]]},"assertion":[{"value":"26 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"There are no conflicts of interest.","order":1,"name":"Ethics","label":"Conflicts of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1767"}}